TNKase (T-N-Kase, tenecteplase), a new thrombolytic for treating heart attacks

Genentech is now introducing TNKase (T-N-Kase, tenecteplase), a new thrombolytic for treating heart attacks.

TNKase is a modified version of Activase (alteplase, tPA). It's made by substituting 3 amino acids of the tPA enzyme.

TNKase and Activase have comparable efficacy for restoring blood flow and improving survival after a heart attack.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote